Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rawlins

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Health Affairs (Project Hope)|March 12, 2009
Comparative effectiveness research: a useful toolDavid Barnett, Kalipso Chalkidou, Michael Rawlins
BMJ (Clinical Research Ed.)|February 17, 2007
When are randomised trials unnecessary? Picking signal from noisePaul Glasziou, Iain Chalmers, Michael Rawlins, et al.
Lancet (London, England)|September 4, 2012
Thalidomide and its sequelaeMichael Emanuel, Michael Rawlins, Gordon Duff, et al.
Lancet (London, England)|April 4, 2006
The future of clinical pharmacology in the UKAlasdair Breckenridge, Colin Dollery, Michael Rawlins, et al.
Lancet (London, England)|May 17, 2011
Science as a public enterprise: the case for open dataGeoffrey Boulton, Michael Rawlins, Patrick Vallance, et al.
Basic & Clinical Pharmacology & Toxicology|July 2, 2010
Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical PharmacologyDonald Birkett, Kim Brøsen, Ingolf Cascorbi, et al.
European Heart Journal|March 23, 2017
Improving public health by improving clinical trial guidelines and their applicationMartin J Landray, Jeroen J Bax, Laurence Alliot, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Health Affairs (Project Hope)|March 12, 2009
Comparative effectiveness research: a useful toolDavid Barnett, Kalipso Chalkidou, Michael Rawlins
BMJ (Clinical Research Ed.)|February 17, 2007
When are randomised trials unnecessary? Picking signal from noisePaul Glasziou, Iain Chalmers, Michael Rawlins, et al.
Lancet (London, England)|September 4, 2012
Thalidomide and its sequelaeMichael Emanuel, Michael Rawlins, Gordon Duff, et al.
Lancet (London, England)|April 4, 2006
The future of clinical pharmacology in the UKAlasdair Breckenridge, Colin Dollery, Michael Rawlins, et al.
Lancet (London, England)|May 17, 2011
Science as a public enterprise: the case for open dataGeoffrey Boulton, Michael Rawlins, Patrick Vallance, et al.
Basic & Clinical Pharmacology & Toxicology|July 2, 2010
Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical PharmacologyDonald Birkett, Kim Brøsen, Ingolf Cascorbi, et al.
European Heart Journal|March 23, 2017
Improving public health by improving clinical trial guidelines and their applicationMartin J Landray, Jeroen J Bax, Laurence Alliot, et al.
Pageof 4